Topamax (topiramate) is now approved to PREVENT migraines

Topamax (topiramate) is now approved to PREVENT migraines.

Nearly half of patients have 50% fewer migraines while on Topamax. This is comparable to current preventive drugs such as tricyclics...divalproex...and beta-blockers.

Patients start on 25 mg/day, then slowly increase up to 50 to 100 mg BID. This is lower than the dose used for seizures.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote